Erythema Multiforme - 25 Studies Found
Recruiting |
: G-CSF in the Treatment of Toxic Epidermal Necrolysis : Stevens - Johnson Syndrome : 2016-04-04 :
|
Not yet recruiting |
: Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis : Toxic Epidermal Necrolysis : 2014-12-15 : Drug: Clobetasol 0.05% ointment Blinded, daily application to one arm for a period of fourteen (14) days |
Available |
: Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation :
|
Withdrawn |
: Topical Infliximab in Autoimmune Eyes With Keratoprosthesis :
: 2014-01-13 : Drug: Palifermin Other Name: Kepivance |
Completed |
: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. :
: 2012-09-20 : Drug: Intravenous immunoglobulin |
Recruiting |
: Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis :
: 2010-11-19 : Drug: Infliximab The drug will be administered intravenously every month for 110 weeks (duration of the |
Completed |
: Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome. :
: Procedure: Salivary Gland and Labial Mucous Membrane Transplantation Minor salivary glands (SG) will be |